{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-001369","form_type":"8-K","ticker":"CGTX","cik":"0001455365","company_name":"COGNITION THERAPEUTICS INC","filed_at":"2024-01-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.234147+00:00","generated_at":"2026-06-07T03:54:33.964686+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Cognition Therapeutics posts January 2024 investor presentation","bullets":["Presentation filed as Exhibit 99.1; covers disease-modifying medicines for neurodegenerative disorders.","No financial results, clinical data, or guidance changes included in the filing.","CEO Lisa Ricciardi signed the 8-K; presentation intended for investor discussions."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-001369","json":"https://secwatch.observer/filing/0001104659-24-001369.json","markdown":"https://secwatch.observer/filing/0001104659-24-001369.md","text":"https://secwatch.observer/filing/0001104659-24-001369.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1455365/000110465924001369/0001104659-24-001369-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1455365/000110465924001369/tm2333729d5_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T03:54:33.964686+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}